VR Speech-Language Therapy for Speech Disorders
Trial Summary
What is the purpose of this trial?
Factors related to successful rehabilitation are often directly related to adherence; for instance, dosage, frequency, and intensity can burden the patient regarding time and motivational factors. Furthermore, surrounding salience, patients may lose interest or find an intervention boring after a few sessions. It is well documented that nonadherence not only impacts rehabilitation for the patient but can also further prolong treatment, and increase hospital and clinician costs, in addition to a higher prevalence of future comorbidities. Therefore, strategies that improve patient adherence can significantly help optimize patient care and treatment outcomes. One avenue to increase patient adherence is through the gamification of rehabilitation therapies using virtual reality (VR). Gamification of rehabilitation therapy can make mass practice required in rehabilitation therapies seemingly fun and more personally engaging for the patient. Additionally, the immersive experience achieved through VR can further promote salience and be customizable to individual patient requirements. As VR systems are now highly portable and relatively simple to utilize, they can provide an excellent opportunity to continue rehabilitation practice on the home front. Overall, the VR gamification of rehabilitation may increase adherence by shifting patients' perspectives of therapy as tedious, boring, or a hassle, to a fun and engaging game that ultimately helps their recovery processes. The GlenXRose VR-delivered speech-language therapies (Cognitive Projections Lab, University of Alberta) have been developed and piloted in collaboration with the Glenrose Rehabilitation Hospital with the overall goal of increasing patient adherence, treatment outcomes, and satisfaction with vocal therapy. The proposed studies are to investigate the feasibility of implementing this technology in routine clinical care (specific to voice disorders), obtaining clinician feedback, examining associated financial costs, and continuing to examine the effect of the GlenXRose VR speech-language therapies on patient adherence and clinical outcomes, compared to traditional clinical care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment GlenXRose Virtual Reality Speech Therapies for speech disorders?
Research shows that virtual reality (VR) can be an effective tool for speech therapy, as it helps improve language skills and communication in people with speech disorders. Studies have found that VR-based therapies can lead to greater improvements in language comprehension, naming, and sentence construction compared to traditional methods, and they also enhance motivation and engagement.12345
How does the VR Speech-Language Therapy treatment differ from other treatments for speech disorders?
VR Speech-Language Therapy is unique because it uses immersive virtual reality to create realistic environments where patients can practice communication skills, which can help them transfer these skills to real-life situations. This approach is different from traditional therapies as it provides a safe, engaging, and interactive way to simulate real-world communication challenges.36789
Research Team
Antonio Miguel Cruz, DrSc
Principal Investigator
University of Alberta
Adriana Rios Rincon, PhD, R.OT
Principal Investigator
University of Alberta
James Raso, MASc
Principal Investigator
Glenrose Rehabilitation Hospital, Alberta Health Services
Eligibility Criteria
This trial is for English-speaking adults with a speech disorder who are currently receiving speech-language therapy at the Glenrose Rehabilitation Hospital. They must be able to consent to participate. It's not for those with substance use disorders, comprehension issues due to communication disorders, severe cognitive or behavioral impairments, or a history of neurological or psychiatric conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive GlenXRose VR-delivered speech-language therapies and standard clinical care
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- GlenXRose Virtual Reality Speech Therapies
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Alberta Health services
Collaborator